Combined modality therapy of gemcitabine and irradiation on human glioma spheroids derived from cell lines and biopsy tissue

Oncology Reports

Volumn 15, Issue 1, 2006, Pages 97-105

  Fehlauer, Fabian ^a,b   Muench, Martina ^a   Smid, Ernst J ^b   Slotman, Ben ^b   Richter, Eckhard ^a   Van Der Valk, Paul ^b   Sminia, Peter ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Gemcitabine; Glioma; Irradiation; Spheroids

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE; KI 67 ANTIGEN; PROTEIN P21; PROTEIN P53; RADIOSENSITIZING AGENT;

APOPTOSIS; ARTICLE; BRAIN TUMOR; CELL MOTION; CELL PROLIFERATION; CONFOCAL MICROSCOPY; DRUG EFFECT; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MULTICELLULAR SPHEROID; MULTIMODALITY CANCER THERAPY; PATHOLOGY; TUMOR CELL LINE;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MICROSCOPY, CONFOCAL; PROTO-ONCOGENE PROTEINS P21(RAS); RADIATION-SENSITIZING AGENTS; SPHEROIDS, CELLULAR; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33644874969     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.1.97     Document Type: Article

References (37)

1. Gonzalez-Gonzalez D and Hulshof MCCM: Neurooncology. In: Primary Tumors and Neurological Complications of Cancer. Radiotherapy. Twijnstra A, Keyser A and Ongerboer de Visser BW (eds). Elsevier, Amsterdam, pp134-158, 1993.
2. Taghian A, Ramsay J and Allalunis-Turner J: Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 25: 243-249, 1993.
3. Bjerkvig R, Tonnesen A, Laerum OD, et al: Multicellular tumor spheroids from human gliomas maintained in organ culture. J Neurosurg 72: 463-475, 1990 (Pubitemid 20072971)
4. Sutherland RM and Durand RE: Hypoxic cells in an in vitro tumor model. Int J Radiat Biol Relat Stud Phys Chem Med 23: 235-246, 1973.
5. Sutherland RM: Cell and environment interactions in tumor microregions: the multicellular spheroid model. Science 240: 177-184, 1988.
6. Kunz-Schughart LA: Multicellular tumor spheroids: intermediates between monolayer culture and in vivo tumor. Cell Biol Int 23: 157-161, 1999.
7. Pauwels B, Korst AE, Lardon F, et al: Combined modality therapy of gemcitabine and radiation. Oncologist 10: 34-51, 2005. (Pubitemid 40171250)
8. Gertler SZ, MacDonald D, Goodyear M, et al: NCIC-CTG phase II study of gemcitabine in patients with malignant glioma. Ann Oncol 11: 315-318, 2000. (Pubitemid 30214669)
9. Weller M, Streffer J, Wick W, et al: Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma. Cancer 91: 423-427, 2001. (Pubitemid 32099245)
10. Rieger J, Durka S, Streffer J, et al: Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasone. Eur J Pharmacol 365: 301-308, 1999. (Pubitemid 29070777)
11. Ostruszka LJ and Shewach DS: The role of cell cycle progression in radiosensitization by 2′,2′-difluoro-2′-deoxycytidine. Cancer Res 60: 6080-6088, 2000.
12. Degen JW, Walbridge S, Vortmeyer AO, et al: Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats. J Neurosurg 99: 893-898, 2003. (Pubitemid 37314926)
13. Genc M, Castro Kreder N, Barten-van Rijbroek A, et al: Enhancement of effects of irradiation by gemcitabine in a glioblastoma cell line and cell line spheroids. J Cancer Res Clin Oncol 130: 45-51, 2004. (Pubitemid 38161247)
14. Akslen LA, Andersen KJ and Bjerkvig R: Characteristics of human and rat glioma cells grown in a defined medium. Anticancer Res 8: 797-803, 1988.
15. Carlsson J, Nilsson K, Westermark B, et al: Formation and growth of multicellular spheroids of human origin. Int J Cancer 31: 523-533, 1983. (Pubitemid 13058328)
16. Mueller-Klieser WF, Freyer JP, Sutherland RM: Influence of glucose and oxygen supply conditions on the oxygenation of multicellular spheroids. Br J Cancer 53: 345-253, 1986.
17. Sutherland R, Freyer J, Mueller-Klieser W, et al: Cellular growth and metabolic adaptations to nutrient stress environments in tumor microregions. Int J Radiat Oncol Biol Phys 12: 611-615, 1986. (Pubitemid 16081623)
18. Fehlauer F, Stalpers LJ, Panayiotides J, et al: Effect of single dose irradiation on human glioblastoma spheroids in vitro. Oncol Rep 11: 477-485, 2004.
19. Kerr JFK, Wyllie AH and Currie AH: Apoptosis, a basic biological phenomenon with wider implications in tissue kinetics. Br J Cancer 26: 239-245, 1972.
20. Fehlauer F, Barten-Van Rijbroek AD, Stalpers LJ, Leenstra S, Lindeman J, Tjahja I, Troost D, Wolbers JG, van der Valk P and Sminia P: Additive cytotoxic effect of cisplatin and X-irradiation on human glioma cell cultures derived from biopsy tissue. J Cancer Res Clin Oncol 126: 711-716, 2000.
21. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000. (Pubitemid 30046295)
22. Kaaijk P, Troost D, Sminia P, et al: Hypofractionated radiation induces a decrease in cell proliferation, but no histological damage to organotypic multicellular spheroids of human glioblastomas. Eur J Cancer 33: 645-651, 1997. (Pubitemid 27223752)
23. Desoize B, Gimonet D and Jardiller JC: Cell culture as spheroids: an approach to multicellular resistance. Anticancer Res 18: 4147-4158, 1998. (Pubitemid 29043627)
24. Santini MT, Rainaldi G and Indovina PL: Multicellular tumour spheroids in radiation biology. Int J Radiat Biol 75: 787-799, 1999. (Pubitemid 29336555)
25. Sutherland RM and Durand RE: Cell contact as a possible contribution to radiation resistance of some tumours. Br J Radiol 45: 788-789, 1972.
26. Olive PL and Durand RE: Drug and radiation resistance in spheroids: cell contact and kinetics. Cancer Metastasis Rev 13: 121-138, 1994. (Pubitemid 24220001)
27. Gerlach A and Acker H: pO2- and pH-gradients in multicellular spheroids and their relationship to cellular metabolism and radiation sensitivity of malignant human tumor cells. Biochim Biophys Acta 1227: 105-112, 1994.
28. Sutherland RM: Tumor hypoxia and gene expression-implications for malignant progression and therapy. Acta Oncol 37: 567-574, 1998.
29. Durand R and Biaglow JE: Radiosensitization of hypoxic cells of an in vitro tumor model by respiratory inhibitors. Radiat Res 69: 359-366, 1977. (Pubitemid 8053733)
30. Biaglow JE, Varnes ME, Jacobson B, et al: Factors influencing the oxygen consumption and radiation response of cultured mammalian cells. Adv Exp Med Biol 159: 347-358, 1983.
31. Sminia P, Acker H, Eikesdal HP, Kaaijk P, Enger P, Slotman B and Bjerkvig R: Oxygenation and response to irradiation of organotypic multicellular spheroids of human glioma. Anticancer Res 23: 1461-1466, 2003. (Pubitemid 36754115)
32. Buffa FM, West C, Byrne K, Moore JV and Nahum AE: Radiation response and cure rate of human colon adenocarcinoma spheroids of different size: the significance of hypoxia on tumor control modelling. Int J Radiat Oncol Biol Phys 49: 1109-1118, 2001. (Pubitemid 32184617)
33. Storniolo AM, Allerheiligen SR and Pearce HL: Preclinical, pharmacologic, and phase I studies of gemcitabine. Semin Oncol 24: 2-7, 1997.
34. Shewach DS and Lawrence TS: Gemcitabine and radiosensitization in human tumor cells. Invest New Drugs 14: 257-263, 1996. (Pubitemid 26383939)
35. Lawrence TS, Eisbruch A and Shewach DS: Gemcitabine mediated radiosensitization. Sem Oncol 24: 24-28, 1997.
36. Neshasteh-Riz A, Angerson WJ, Reeves JR, Smith G, Rampling R and Mairs RJ: Incorporation of iododeoxyuridine in multicellular glioma spheroids: implications for DNA-targeted radiotherapy using Auger electron emitters. Br J Cancer 75: 493-499, 1997. (Pubitemid 27085288)
37. Barendsen GW, Van Bree C and Franken NA: Importance of cell proliferative state and potentially lethal damage repair on radiation effectiveness: implications for combined tumor treatments. Int J Oncol 19: 247-256, 2001.